# US 2013/0157356 A1 · Methods & compositions for improving protein production

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157356 A1
- Document ID: US20130157356A1
- Status: Published application
- Kind: A1
- Application number: 13/575,131
- Filed: 2011-01-24
- Published: 2013-06-20
- Earliest claimed: 2010-01-25
- Assignees: Ventria Bioscience
- Inventors: Michael E. Barnett; Matthew S. Croughan
- Web page: https://patentgrep.com/patent/US20130157356A1

## CPC

- C12N 5/0018: {Culture media for cell or tissue culture (media for specific animal cell type C12N5/06)}
- C07K 14/765: Serum albumin, e.g. HSA
- C12N 15/8257: {for the production of primary gene products, e.g. pharmaceutical products, interferon}
- C12N 2500/76: from plants
- C12N 2500/84: from mammals
- C12N 2500/92: Medium free of human- or animal-derived components
- C12N 2501/998: Proteins not provided for elsewhere
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The invention relates to compositions, and uses thereof, which are beneficial for eukaryotic cells in culture, and methods for their use in promoting cell growth, viability and recombinant protein expression. The methods disclosed in the present application are useful, for example, for improving cell viability and in accelerating the rate of cell growth of cells grown in culture. In one aspect, the supplements of the invention are useful for improving or enhancing the yield of the recombinant proteins from the cell cultures.

## Claims

### Claim at position 1

1-72. (canceled)

### Claim 73

A method for enhancing the growth of a cell growing in cell culture medium, comprising adding a supplement comprising recombinant albumin to said cell culture medium,
wherein said recombinant albumin is produced in a plant;
wherein said supplement has less than about 1 EU of endotoxin per mg of albumin; and
wherein said albumin comprises less than about 2% aggregated albumin.

### Claim 74

A method for enhancing the productivity of a cell that has been adapted to serum free media, comprising adding a supplement comprising recombinant albumin to said serum free media,
wherein said recombinant albumin is produced in a plant;
wherein said supplement has less than about 1 EU of endotoxin per mg of albumin; and
wherein said albumin comprises less than about 2% aggregated albumin.

### Claim 75 (depends on 73, 74)

The method of claim 73 or 74, wherein said cell is a tissue culture cell.

### Claim 76 (depends on 73, 74)

The method of claim 73 or 74, wherein said cell is selected from the group consisting of a CHO cell, a hybridoma cell, a Vero cell, or a primary cell.

### Claim 77 (depends on 76)

The method of claim 76, wherein said primary cell is a stem cell.

### Claim 78 (depends on 76)

The method of claim 76, wherein said primary cell is B-cell derived.

### Claim 79 (depends on 76)

The method of claim 76, wherein said primary cell is a B-cell.

### Claim 80 (depends on 76)

The method of claim 76, wherein said primary cell is T-cell derived.

### Claim 81 (depends on 76)

The method of claim 76, wherein said primary cell is a T-cell.

### Claim 82 (depends on 73, 74)

The method of claim 73 or 74, wherein said supplement comprises at least about 0.01% wt/wt of a heat shock protein.

### Claim 83 (depends on 82)

The method of claim 82, wherein said heat shock protein is a rice heat shock protein.

### Claim 84 (depends on 83)

The method of claim 83, wherein said rice heat shock protein is selected from the group consisting of rice HSP70 and rice endosperm lumenal binding protein.

### Claim 85 (depends on 83)

The method of claim 83, wherein said rice heat shock protein is selected from the group consisting of rice (gblACJ54890.1l), EEC69073/OsI—37938, and AAB63469.

### Claim 86 (depends on 84)

The method of claim 84, wherein said supplement comprises at least about 0.01% wt/wt HSP 70, at least about 0.04% wt/wt HSP 70, at least about 0.06% wt/wt HSP 70, at least about 0.08% wt/wt HSP 70, or at least about 0.1% wt/wt HSP 70.

### Claim 87 (depends on 73, 74)

The method of claim 73 or 74, wherein said recombinant albumin is added to a final concentration of between about 100 mg/L and about 200 mg/L, between about 200 mg/L and about 400 mg/L, between about 400 mg/L and about 600 mg/L, between about 600 mg/L and about 800 mg/L, between about 800 mg/L and about 1000 mg/L, between about 1000 mg/L and about 2000 mg/L, between about 2000 mg/L and about 5000 mg/L, between about 5000 mg/L and about 10000 mg/L, or between about 10000 mg/L and about 20000 mg/L.
